Pharmafile Logo
Pharmafocus logo
Advanced Search

Genetics revolution set for NHS

October 29, 2003

News

Biotech consolidation picks up with $6.4bn deal

October 29, 2003

The recent run of biotech consolidation has stepped up a gear as Biogen and Idec have agreed a $6.4 billion …

News

Foundation status reform not most important, say trusts

October 29, 2003

The Government's plans for foundations hospitals will have much less impact on the NHS than other reforms of the health …

News

Novartis buys Pfizer incontinence drug

October 29, 2003

Novartis has bought Pfizer's incontinence product Enablex ahead of the US giant's merger with Pharmacia.The drug is one of several …

News

Look closer – The importance of local opinion leaders

October 29, 2003
Sales and Marketing key opinion leaders

There is no doubt that key opinion leader (KOL) development has always been a crucial component of the marketing mix; …

Feature

Government to limit pharmacy reform

October 29, 2003

News

Roche survey shows cancer postcode prescribing continues

October 29, 2003

A new UK-wide survey by Roche has shown a third of breast cancer patients who could benefit from its NICE-approved …

News

Limited lifting of NICE ‘ban’ on Tamiflu

October 29, 2003
Sales and Marketing

Roche have won a limited recommendation for its flu drug Tamiflu following a second NICE approval.An appraisal of flu drugs …

News

The new GP contract : incentives for pharma too

October 29, 2003
GP contract, NHS, healthcare

As the final details of the new GP contract are decided, the pharmaceutical industry is now preparing itself for a …

Feature

Betaferon and Avonex in head-to-head MS trial

October 29, 2003
Research and Development, Sales and Marketing

Schering AG is to launch the largest ever therapeutic multiple sclerosis trial, comparing its drug Betaferon with Biogen's rival Avonex.The …

News

AstraZeneca accused of blocking Losec competition

October 29, 2003
Sales and Marketing

News

Aventis awards ClinPhone preferred supplier status

October 29, 2003
Research and Development

Aventis has made ClinPhone its preferred provider for data management of it clinical trials worldwide.Specialists in telephone and internet-based electronic …

News

Do doctors really use the Internet?

October 29, 2003
Sales and Marketing doctors, internet

Ever since the medical and pharmaceutical web emerged in the mid-90s, technology advocates have assumed that widespread use of the …

Feature

Celltech takes 10% stake in OGS

October 29, 2003
Sales and Marketing

News

New GSK joint venture malaria drug approved

October 29, 2003
Research and Development

News

Zyprexa approved for bipolar disorder

October 29, 2003
Sales and Marketing

Eli Lilly's market-leading schizophrenia drug Zyprexa has been granted European approval for the long-term treatment of bipolar disorder.The approval makes …

News

New HRT study shows doubling of cancer risk

October 29, 2003
Research and Development

A new study of over one million UK women has confirmed an increased risk of breast cancer from all forms …

News

Retaining the talent you recruit

October 29, 2003
Business Services recruitment, strategy

The vast majority of people who want to work in the pharma industry have high ideals and wish to be …

Feature

Merck expands into US proteomics

October 29, 2003
Research and Development

Merck KGaA has bought ProtoPlex, a US-based biotech company specialising in functional genomics and proteomics.Privately owned Protoplex will be integrated …

News

Shire cuts back ahead of US expansion

October 29, 2003
Sales and Marketing

Shire Pharmaceuticals is to revert to its original business model of marketing and developing specialist drugs in late stage clinical …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025